Last reviewed · How we verify
Oral Vitamin D Supplementation
At a glance
| Generic name | Oral Vitamin D Supplementation |
|---|---|
| Also known as | Vitamin D3-Cholecalciferol 1000units per tablet., A11CC05 Colecalciferol |
| Sponsor | Winthrop University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients (PHASE2)
- Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease (NA)
- Protein Supplement and Exercise Training for the Treatment of Sarcopenia Risk in Older Adults (NA)
- Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency (NA)
- Effect of Vitamin D Supplementation on Metabolic Parameters in Patients With Type 2 Diabetes and Vitamin D Deficiency (NA)
- Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma (PHASE2)
- A Study of a Dietary Supplement on Serum Biomarkers in Children (NA)
- Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury. (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oral Vitamin D Supplementation CI brief — competitive landscape report
- Oral Vitamin D Supplementation updates RSS · CI watch RSS
- Winthrop University Hospital portfolio CI